3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Active not recruiting
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Malnutrition
3
Breast Neoplasms
2
Weight Gain
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Stomach Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Nutrition Disorders
1
Neoplasms
1
Muscular Atrophy
1
Motor Activity
1
Gastrointestinal Neoplasms
1
Fatigue
1
Cachexia
1
Interventions
Paclitaxel
35
Carboplatin
35
Bevacizumab
14
olaparib
13
niraparib
11
apatinib
11
Gemcitabine
10
liposomal doxorubicin
9
Hyperthermic Intraperitoneal Chemotherapy
9
Cisplatin
9
pembrolizumab
8
Cyclophosphamide
8
fludarabine
7
Etoposide
7
Topotecan
6
fluzoparib
5
Surveys and Questionnaires
5
Drug Therapy
5
Albumin-Bound Paclitaxel
5
anlotinib
4
Immunohistochemistry
4
Ifosfamide
4
Doxorubicin
4
Docetaxel
4
Cytoreduction Surgical Procedures
4
Taxes
3
Surgical Procedures, Operative
3
Poly(ADP-ribose) Polymerase Inhibitors
3
Neoadjuvant Therapy
3
Laparoscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Ovarian Neoplasms
×
Diet Therapy
×
Clear all
NCT06250686
2024-02-09
BENITA
Universitätsklinikum Hamburg-Eppendorf
Phase NA
Unknown
185 enrolled